DeepEn GmbH, a pioneer in holographic endoscopy, has successfully closed a seven-digit seed financing round with investors bm|t, MBG Thüringen and Sparkasse Jena-Saale-Holzland. This investment will accelerate the development and commercialization of the world’s thinnest microscopy instruments, which will open up new possibilities for neuroscience and biomedical research.
In addition, the NEUROGATE project, a collaboration between the start-up and three European research institutes, received funding of 2.5 million euros from the European Innovation Council (EIC) Transition Program in January 2025. Together, the consortium aims to further develop the minimally invasive technology for a variety of new applications.
Investment in neurophotonics innovation
DeepEn’s endoscopes use advanced algorithms and holographic techniques to precisely control laser light as it passes through a single optical fiber. Once the fiber is inserted into an organ such as the brain, it can focus the light beam to a clean focal point, enabling laser scanning microscopy in previously inaccessible deep tissue regions. The innovative technology was honored with the European Microscopy Society’s Life Sciences Award 2024.
Prototypes of these microscopy devices have already been used to image neurons and cancer cells in animal models. With the investment, the DeepEn team, led by CEO Dr. Sergey Turtaev, plans to launch its first product, the NeuroDeep® in vivo microscopy system, as well as develop the next generation of holographic endoscope technology for even more advanced applications.
With bm|t, MBG Thüringen and Sparkasse Jena-Saale-Holzland, DeepEn has gained three experienced investors with valuable expertise in the optical ecosystem of Central Germany. “We warmly welcome our new investors and thank them for their confidence in our team and our technology,” says Turtaev. “Together, we are pursuing our vision of enabling innovative diagnostic and therapeutic approaches for neuronal diseases through our powerful imaging tools.”
Successful transfer of cutting-edge research
The foundations of holographic endoscopy were developed from 2011 onwards by Prof. Dr. Tomas Čižmár, a later co-founder of DeepEn, at the University of St. Andrews and the University of Dundee in Scotland. In 2016, Sergey Turtaev joined the research group during his doctorate. In 2017, the scientists moved to the Leibniz Institute of Photonic Technology (Leibniz IPHT) in Jena, where they continued their work as part of the prestigious ERC Consolidator Grant LIFEGATE.
Commercialization began in 2020 through the EXIST program for research transfer funding from the German Federal Ministry of Economics and Climate Protection, which led to the spin-off of DeepEn GmbH in early 2024. “This company is a prime example of how top-class research, which has led to outstanding publications, is quickly turned into a marketable product,” says Prof. Dr. Jürgen Popp, Scientific Director of Leibniz IPHT. “The team’s speed and dedication are impressive.”
DeepEn was one of the 25 winners of the Falling Walls Venture Cup in fall 2024 and received the Thuringian Innovation Award for young companies.
European cooperation for technology transfer
The potential of holographic endoscopy has also been recognized in Brussels. In January 2025, the NEUROGATE cooperation project received funding of 2.5 million euros from the European Innovation Council (EIC) Transition as part of Horizon Europe. “With this project, we are transforming the latest scientific discoveries into valuable solutions for users. In this way, we enable precise monitoring of neuronal activity under natural conditions with unprecedented accuracy,” says Prof. Čižmár.
In addition to Leibniz IPHT and DeepEn, two international partners are involved in NEUROGATE: the Institute of Scientific Instruments (ISI) of the Czech Academy of Sciences in Brno and Neuro-Electronics Research Flanders (NERF) in Belgium. The interdisciplinary research center for neurotechnology is supported by imec, the Life Sciences Institute VIB and the KU Leuven. “We look forward to contributing our expertise to the further development of neurotechnological applications in order to better understand the brain and develop new therapeutic strategies for neurological diseases,” says Sebastian Haesler from NERF.
The investors
About bm|t: bm|t, based in Erfurt, is the leading address for corporate investments in Thuringia. bm|t currently manages twelve funds with a total volume of around 445 million euros, which invest in innovative companies in almost all sectors and development phases — whether in the start-up and growth phase or for company successions. Further information can be found at: www.bm‑t.de
About Sparkasse Jena-Saale-Holzland: Sparkasse Jena-Saale-Holzland has been rooted in the region since 1828 and offers financial services, advice and funding for companies and communities. As the largest regional financial partner, it improves the quality of life through digitalization, financing and public programs. The Sparkasse actively supports the economy, education, sport and culture in the region. It promotes innovation by supporting start-ups such as DeepEn GmbH and, together with the Business Angels Club Jena e.V., has created a platform that connects start-ups with private investors in order to strengthen the regional start-up ecosystem. More information: www.s‑jena.de
About MBG Thüringen: Mittelständische Beteiligungsgesellschaft Thüringen mbH (MBG Thüringen) is a strong and reliable partner for small and medium-sized enterprises. It offers mezzanine and equity investments to strengthen the equity base of companies for start-up, consolidation or succession planning. This gives companies a solid basis for sustainable growth. More information: www.mbg-thueringen.de
